Schedule 13D for Iridex Corporation
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)
Iridex Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
462684101
(CUSIP Number)
Scott A. Shuda
BlueLine Partners, LLC
4115 Blackhawk Plaza Circle, Suite 100
Danville, California 94506
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
Copy to:
James C. Creigh
Blackwell Sanders Peper Martin LLP
1620 Dodge Street, Suite 2100
Omaha, Nebraska 68102
(402) 964-5000
December 6, 2005
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the
following box [ ].
Page 1 of 8
----------------------------
CUSIP No. 462684101 -
----------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON/
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
BlueLine Capital Partners, L.P.
---------- ---------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
2 Instructions) (a) [ ]
(b) [ X ]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
WC
---------- ---------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
---------- ---------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------- ----- ----------------------------------------------
- 7 SOLE VOTING POWER
- 0
NUMBER OF - ----- ----------------------------------------------
SHARES - 8 SHARED VOTING POWER
BENEFICIALLY - 350,092
OWNED BY EACH - ----- ----------------------------------------------
REPORTING - 9 SOLE DISPOSITIVE POWER
PERSON - 0
WITH - ----- ----------------------------------------------
- 10 SHARED DISPOSITIVE POWER
- 350,092
--------------------------- ----- ----------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
350,092
---------- ---------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES [ ]
(See Instructions)
---------- ---------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.7%
---------- ---------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
---------- ---------------------------------------------------------------------
Page 2 of 8
----------------------------
CUSIP No. 462684101 -
----------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON/
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
BlueLine Catalyst Fund VIII, L.P.
---------- ---------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
2 Instructions) (a) [ ]
(b) [ X ]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
WC
---------- ---------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
---------- ---------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------- ----- ----------------------------------------------
- 7 SOLE VOTING POWER
- 0
NUMBER OF - ----- ----------------------------------------------
SHARES - 8 SHARED VOTING POWER
BENEFICIALLY - 163,420
OWNED BY EACH - ----- ----------------------------------------------
REPORTING - 9 SOLE DISPOSITIVE POWER
PERSON - 0
WITH - ----- ----------------------------------------------
- 10 SHARED DISPOSITIVE POWER
- 163,420
--------------------------- ----- ----------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
163,420
---------- ---------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES [ ]
(See Instructions)
---------- ---------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.2%
---------- ---------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
---------- ---------------------------------------------------------------------
Page 3 of 8
----------------------------
CUSIP No. 462684101 -
----------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON/
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
BlueLine Partners, L.L.C.
---------- ---------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
2 Instructions) (a) [ ]
(b) [ X ]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
WC
---------- ---------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
---------- ---------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------- ----- ----------------------------------------------
- 7 SOLE VOTING POWER
- 0
NUMBER OF - ----- ----------------------------------------------
SHARES - 8 SHARED VOTING POWER
BENEFICIALLY - 513,512
OWNED BY EACH - ----- ----------------------------------------------
REPORTING - 9 SOLE DISPOSITIVE POWER
PERSON - 0
WITH - ----- ----------------------------------------------
- 10 SHARED DISPOSITIVE POWER
- 513,512
--------------------------- ----- ----------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
513,512
---------- ---------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES [ ]
(See Instructions)
---------- ---------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.85%
---------- ---------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
---------- ---------------------------------------------------------------------
Page 4 of 8
This Amendment No. 1 (this "Amendment") amends and supplements the statement on
Schedule 13D filed by BlueLine Capital Partners, LP, ("BCP"), BlueLine Catalyst
Fund VIII, L.P. and BlueLine Partners, L.L.C. ("BlueLine Partners" and, together
with BlueLine Catalyst, the "Reporting Entities") on September 19, 2005 (the
"Schedule 13D"), relating to the common stock (the "Common Stock") of Iridex
Corporation (the "Company"). Items designated as "no change" indicate that the
information previously included in the Schedule 13D remains current as of the
date of this Amendment.
Item 1. Security and Issuer
No change.
Item 2. Identity and Background
No change.
Item 3. Source and Amount of Funds
As of the date hereof, the Reporting Entities may, in the aggregate, be deemed
to beneficially own 513,512 shares of the Common Stock (the "Shares"). The
Shares were purchased in the open market by BCP and BlueLine Catalyst VIII with
their investment capital.
Item 4. Purpose of the Transaction
No change.
Item 5. Interest in Securities of the Issuer
(a) As of the date of this Schedule 13D, each of the Reporting Entities may be
deemed to own 513,512 shares of Common Stock. These shares represent
approximately 6.85% of the shares of Common Stock outstanding based on
7,497,361 shares of the Company's Common Stock outstanding as reported in
the Company's Form 10-Q for the Company's fiscal quarter ended October 1,
2005 as filed with the Securities and Exchange Commission on November 15,
2005.
The Reporting Entities are making this single, joint filing because they
may be deemed to constitute a "group" within the meaning of Section
13(d)(3) of the Act. Each Reporting Entity expressly disclaims beneficial
ownership of any of the shares of Common Stock other than those reported
herein as being owned by it.
(b) As of the date of this Schedule 13D: (i) BCP beneficially owns 350,092
shares of Common Stock with which BCP has shared voting power and shared
dispositive power with the other Reporting Entities; (ii) BlueLine Catalyst
VIII beneficially owns 163,420 shares of Common Stock with which BlueLine
Catalyst VIII has shared voting power and shared dispositive power with the
other Reporting Entities; and (iii) BlueLine Partners beneficially owns
513,512 shares of Common Stock with which BlueLine Partners has shared
voting power and shared dispositive power with the other Reporting
Entities.
Page 5 of 8
(c) Information concerning transactions in the Common Stock effected by the
Reporting Entities during the past sixty days is set forth in Exhibit B
hereto and is incorporated by this reference. All of the transactions set
forth in Exhibit B were open market transactions for cash.
(d) No person (other than the Reporting Entities) is known to have the right to
receive or the power to direct the receipt of dividends from, or the
proceeds from the sale of, the Shares.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer
Pursuant to Rule 13d-1(k) promulgated under the Act, the Reporting Entities have
entered into an agreement with respect to the joint filing of this statement,
and any amendment or amendments hereto, which is attached hereto as Exhibit A.
Item 7. Materials to be Filed as Exhibits
1. Exhibit A - Joint Filing Agreement dated September 15, 2005, signed by
each of the Reporting Entities in order to confirm that this Schedule
13D is being filed on behalf of each of the Reporting Entities.*
2. Exhibit B - Transactions in the Common Stock by the Reporting Entities
during the past 60 days.
* Incorporated by reference to the original Schedule 13D filed on
September 29, 2005.
Page 6 of 8
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: December 15, 2005
BlueLine Capital Partners, L.P.
By: BlueLine Partners, L.L.C.
Its: General Partner
By: /s/ Scott Shuda
--------------------------------------
Name: Scott Shuda
Title: Managing Director
BlueLine Catalyst Fund VIII, L.P.
By: BlueLine Partners, L.L.C.
Its: General Partner
By: /s/ Scott Shuda
--------------------------------------
Name: Scott Shuda
Title: Managing Director
BlueLine Partners, L.L.C.
By: /s/ Scott Shuda
--------------------------------------
Name: Scott Shuda
Title: Managing Director
Page 7 of 8
EXHIBIT B
Transactions in the Common Stock effected by the Reporting Entities during the
past sixty days.
BlueLine Catalyst VIII BCP
Date No. of Shares Price per Share No. of Shares Price per Share
10/17/2005 1,000 $ 8.38
10/19/2005 700 $ 8.36
10/21/2005 700 $ 8.64
10/28/2005 2,000 $ 8.00
11/2/2005 1000 $ 7.90
11/3/2005 1500 $ 7.75
11/9/2005 3000 $ 7.73
11/11/2005 200 $ 7.53
11/14/2005 9,000 $ 7.16
11/15/2005 3000 $ 7.03
11/16/2005 1000 $ 7.29
11/17/2005 9,000 $ 7.05
11/18/2005 5,000 $ 7.02
11/21/2005 1,600 $ 7.04
11/23/2005 4,000 $ 7.01
11/28/2005 1,200 $ 7.02
11/29/2005 5075 $ 7.39
12/1/2005 14,400 $ 7.00
12/5/2005 3000 $ 6.99
12/6/2005 8,000 $ 6.88
12/7/2005 17,000 $ 6.47
12/9/2005 13,000 $ 6.39
12/12/2005 500 $ 6.19
12/13/2005 1,000 $ 6.50
12/14/2005 2,600 $ 6.37
Page 8 of 8